Curasight doses first patient in Phase I brain cancer trial of uTREAT
Denmark-based Curasight has dosed the first patient in the Phase I clinical trial of its uTREAT diagnostic platform, targeting high-grade…
News
Abbott secures FDA and CE Mark approvals for Amplatzer delivery system
EDX Medical plans UK bowel cancer testing service launch
New report highlights challenges hampering hospital connected device security
MARAbio introduces MAR-Autism Test to detect maternal autoantibodies
FDA clears SleepRes’ Kricket PAP device for obstructive sleep apnoea
FDA clears CMR Surgical’s Versius Plus robot
Sanome to roll out AI infection detection tool in two UK hospitals
